Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.
about
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.Recent advances in therapy of chronic lymphocytic leukaemia.Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
P2860
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluating abbreviated inducti ...... chronic lymphocytic leukemia.
@en
type
label
Evaluating abbreviated inducti ...... chronic lymphocytic leukemia.
@en
prefLabel
Evaluating abbreviated inducti ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Evaluating abbreviated inducti ...... chronic lymphocytic leukemia.
@en
P2093
Alain Delmer
Anne-Sophie Michallet
Bruno Cazin
Caroline Dartigeas
Christian Berthou
Eric Van Den Neste
Florence Cymbalista
Hervé Maisonneuve
Jean-Pierre Vilque
Kamel Laribi
P2860
P356
10.3109/10428194.2015.1063139
P577
2015-07-03T00:00:00Z